| Disease | Acute lymphocytic leukemia (ALL), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CML), chronic lymphocytic leukemia (CLL) and non Hodgkin lymphomas (NHL). |
| Phenotype / cell stem origin | Most ALL are B-lineage, few T-lineage. AML: most subtypes. CML: Lymphomas: described in follicular, diffuse large B-cell, mantle cell and anaplastic large cell, as well as Hodgkin lymphomas. |
| Epidemiology | Rare in childhood ALL (about 1%), more common in infant ALL (about 13%). Very rare in AML, adult ALL, CLL and lymphomas. Occurs in primary and secondary leukemias. CML: rare, occurs as secondary abnormality or part of complex Ph rearrangement |
| Prognosis | Childhood ALL: No increased risk with current treatment regimens. Outcome not described in other diseases. |
| Fluorescence in situ hybridization characterization of new translocations involving TEL (ETV6) in a wide spectrum of hematologic malignancies. |
| Wlodarska I, La Starza R, Baens M, Dierlamm J, Uyttebroeck A, Selleslag D, Francine A, Mecucci C, Hagemeijer A, Van den Berghe H, Marynen P |
| Blood. 1998 ; 91 (4) : 1399-1406. |
| PMID 9454771 |
| |
| Abnormalities of chromosome bands 15q13-15 in childhood acute lymphoblastic leukemia. |
| Heerema NA, Sather HN, Sensel MG, La MK, Hutchinson RJ, Nachman JB, Reaman GH, Lange BJ, Steinherz PG, Bostrom BC, Gaynon PS, Uckun FM |
| Cancer. 2002 ; 94 (4) : 1102-1110. |
| PMID 11920481 |
| |
| Cytogenetic features of infants less than 12 months of age at diagnosis of acute lymphoblastic leukemia: impact of the 11q23 breakpoint on outcome: a report of the Childrens Cancer Group. |
| Heerema NA, Arthur DC, Sather H, Albo V, Feusner J, Lange BJ, Steinherz PG, Zeltzer P, Hammond D, Reaman GH |
| Blood. 1994 ; 83 (8) : 2274-2284. |
| PMID 8161794 |
| |